IDEXX Laboratories Reports Strong Q4 Results and 2026 Outlook
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5d ago
0mins
Should l Buy IDXX?
Source: Benzinga
- Earnings Beat: IDEXX Laboratories reported Q4 2025 earnings of $3.08 per share, an 18% year-over-year increase that surpassed the consensus estimate of $2.94, indicating robust performance in the animal health sector.
- Sales Growth: The company achieved sales of $1.091 billion in Q4, exceeding the consensus of $1.073 billion and reflecting a 14% year-over-year growth, particularly driven by strong demand in the CAG Diagnostics segment.
- 2026 Outlook: IDEXX forecasts earnings per share for fiscal 2026 to be between $14.29 and $14.80, slightly above the consensus of $14.39, demonstrating confidence in future growth prospects.
- Analyst Rating Adjustments: BTIG analyst lowered the price target for IDEXX from $830 to $800 while maintaining a Buy rating, and UBS analyst reduced the target from $750 to $730 with a Neutral rating, reflecting a cautious market sentiment regarding the company's outlook.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy IDXX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on IDXX
Wall Street analysts forecast IDXX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IDXX is 792.78 USD with a low forecast of 750.00 USD and a high forecast of 850.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
7 Buy
3 Hold
0 Sell
Moderate Buy
Current: 643.590
Low
750.00
Averages
792.78
High
850.00
Current: 643.590
Low
750.00
Averages
792.78
High
850.00
About IDXX
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
IDEXX Laboratories Reports Strong Q4 Results and 2026 Outlook
- Earnings Beat: IDEXX Laboratories reported Q4 2025 earnings of $3.08 per share, an 18% year-over-year increase that surpassed the consensus estimate of $2.94, indicating robust performance in the animal health sector.
- Sales Growth: The company achieved sales of $1.091 billion in Q4, exceeding the consensus of $1.073 billion and reflecting a 14% year-over-year growth, particularly driven by strong demand in the CAG Diagnostics segment.
- 2026 Outlook: IDEXX forecasts earnings per share for fiscal 2026 to be between $14.29 and $14.80, slightly above the consensus of $14.39, demonstrating confidence in future growth prospects.
- Analyst Rating Adjustments: BTIG analyst lowered the price target for IDEXX from $830 to $800 while maintaining a Buy rating, and UBS analyst reduced the target from $750 to $730 with a Neutral rating, reflecting a cautious market sentiment regarding the company's outlook.
See More
Wall Street Analysts Adjust ROKU Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their outlook on ROKU stock, indicating a divergence in market sentiment regarding the company's future prospects, which could influence investor decisions and market mood.
- Market Reaction Monitoring: While specific rating changes were not detailed, analysts' opinions typically have a direct impact on stock prices, prompting investors to closely monitor subsequent market developments.
- Impact of Rating Changes: Upgrades or downgrades from analysts can lead to short-term volatility in ROKU's stock, making it essential for investors to consider these rating changes in their investment strategies.
- Investor Recommendations: When considering the purchase of ROKU stock, investors are advised to reference the latest analyst ratings and market trends to make more informed investment decisions.
See More
Market Sentiment Improves as Stocks Rise
- Improved Market Sentiment: The CNN Money Fear & Greed Index rose to 61.2 on Monday from 56.1, indicating a shift towards 'Greed' and potentially boosting investor confidence and market activity.
- Strong Stock Performance: The Dow Jones surged over 500 points to close at 49,407.66, while the S&P 500 and Nasdaq gained 0.54% and 0.56%, respectively, reflecting a positive overall market trend.
- Positive Economic Data: The ISM Manufacturing PMI increased to 52.6 in January from 47.9, surpassing market expectations of 48.5, suggesting a rebound in manufacturing activity that could drive economic growth and improve corporate earnings outlook.
- Significant Stock Volatility: Despite Walt Disney Co. reporting better-than-expected quarterly results, its stock fell over 7%, and IDEXX Laboratories slid around 5% after issuing cautious guidance, indicating market concerns over individual company prospects.
See More
US Stocks Close Higher on Strong Manufacturing Data
- Manufacturing Index Surge: The US January ISM manufacturing index rose by 4.7 to 52.6, surpassing expectations of 48.5, marking the strongest expansion in over 3.25 years, which bolstered market optimism and contributed to stock gains.
- Chip Stocks Rally: Chipmakers and AI infrastructure stocks performed strongly on Monday, with Sandisk (SNDK) surging over 15% to lead the S&P 500 gainers, reflecting strong demand for tech stocks and a recovery in investor confidence.
- Energy Stocks Under Pressure: Energy producers faced headwinds as WTI crude oil prices fell more than 4%, with Diamondback Energy (FANG) and Occidental Petroleum (OXY) both declining over 3%, indicating growing concerns in the energy sector.
- Cryptocurrency Market Retreats: Bitcoin plummeted over 7% to a 9.75-month low, leading to widespread declines in cryptocurrency-related stocks, with Galaxy Digital Holdings (GLXY) and Strategy (MSTR) both dropping over 6%, reflecting weakened investor confidence in the crypto market.
See More
US Stocks Rise as Chip and Rare Earth Stocks Rebound
- Market Recovery: The S&P 500 index rose by 0.39%, the Dow Jones Industrial Average increased by 0.84%, and the Nasdaq 100 climbed by 0.64%, reflecting positive market sentiment driven by strong economic signals, particularly following the expansion of the manufacturing index.
- Rare Earth Stocks Surge: President Trump's plan to launch a $12 billion strategic stockpile of critical minerals to reduce reliance on China has led to a rise in US rare earth stocks, with USA Rare Earth up over 12% and United States Antimony Corp up over 6%, indicating a positive impact from supportive policies on the sector.
- Energy Stocks Under Pressure: WTI crude oil prices fell by more than 4%, primarily due to easing geopolitical risks, putting pressure on energy producers, with companies like ConocoPhillips and Chevron seeing declines of over 2%, reflecting market concerns about energy demand prospects.
- Cryptocurrency Market Retreats: Bitcoin prices dropped over 7% to a 9.75-month low, leading to widespread declines in cryptocurrency-related stocks, with Galaxy Digital Holdings down more than 4%, highlighting a weakening market confidence in crypto assets.
See More
Wall Street Rebounds as Precious Metals Face Pressure
- Market Rebound: Wall Street experienced a rebound at the start of the new month, with the S&P 500 rising 0.7% and the Nasdaq 100 gaining 1.1%, while the Russell 2000 rebounded 1.4% after a 1.6% drop, indicating strong performance in small-cap stocks and reflecting improved investor sentiment.
- Pressure on Precious Metals: Gold prices extended Friday's decline, sliding over 4% to $4,670 per ounce, while silver plummeted 8% to $77.88, indicating ongoing pressure in the precious metals market as investors reassess the Federal Reserve's policy outlook.
- Positive Economic Data: The ISM Manufacturing PMI unexpectedly surged to a three-year high, signaling renewed momentum in factory activity and boosting market confidence in economic recovery, despite the Bureau of Labor Statistics delaying the release of January's jobs report due to the partial government shutdown.
- Energy Market Volatility: Natural gas prices plunged 25% on milder weather forecasts, while crude oil dropped over 5% as the U.S. administration prepared for nuclear deal talks with Iranian officials, highlighting the impact of geopolitical factors on energy markets.
See More
IDEXX Laboratories Reports Strong Q4 Results and 2026 Outlook
- Earnings Beat: IDEXX Laboratories reported Q4 2025 earnings of $3.08 per share, an 18% year-over-year increase that surpassed the consensus estimate of $2.94, indicating robust performance in the animal health sector.
- Sales Growth: The company achieved sales of $1.091 billion in Q4, exceeding the consensus of $1.073 billion and reflecting a 14% year-over-year growth, particularly driven by strong demand in the CAG Diagnostics segment.
- 2026 Outlook: IDEXX forecasts earnings per share for fiscal 2026 to be between $14.29 and $14.80, slightly above the consensus of $14.39, demonstrating confidence in future growth prospects.
- Analyst Rating Adjustments: BTIG analyst lowered the price target for IDEXX from $830 to $800 while maintaining a Buy rating, and UBS analyst reduced the target from $750 to $730 with a Neutral rating, reflecting a cautious market sentiment regarding the company's outlook.
See More
Wall Street Analysts Adjust ROKU Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their outlook on ROKU stock, indicating a divergence in market sentiment regarding the company's future prospects, which could influence investor decisions and market mood.
- Market Reaction Monitoring: While specific rating changes were not detailed, analysts' opinions typically have a direct impact on stock prices, prompting investors to closely monitor subsequent market developments.
- Impact of Rating Changes: Upgrades or downgrades from analysts can lead to short-term volatility in ROKU's stock, making it essential for investors to consider these rating changes in their investment strategies.
- Investor Recommendations: When considering the purchase of ROKU stock, investors are advised to reference the latest analyst ratings and market trends to make more informed investment decisions.
See More
Market Sentiment Improves as Stocks Rise
- Improved Market Sentiment: The CNN Money Fear & Greed Index rose to 61.2 on Monday from 56.1, indicating a shift towards 'Greed' and potentially boosting investor confidence and market activity.
- Strong Stock Performance: The Dow Jones surged over 500 points to close at 49,407.66, while the S&P 500 and Nasdaq gained 0.54% and 0.56%, respectively, reflecting a positive overall market trend.
- Positive Economic Data: The ISM Manufacturing PMI increased to 52.6 in January from 47.9, surpassing market expectations of 48.5, suggesting a rebound in manufacturing activity that could drive economic growth and improve corporate earnings outlook.
- Significant Stock Volatility: Despite Walt Disney Co. reporting better-than-expected quarterly results, its stock fell over 7%, and IDEXX Laboratories slid around 5% after issuing cautious guidance, indicating market concerns over individual company prospects.
See More
US Stocks Close Higher on Strong Manufacturing Data
- Manufacturing Index Surge: The US January ISM manufacturing index rose by 4.7 to 52.6, surpassing expectations of 48.5, marking the strongest expansion in over 3.25 years, which bolstered market optimism and contributed to stock gains.
- Chip Stocks Rally: Chipmakers and AI infrastructure stocks performed strongly on Monday, with Sandisk (SNDK) surging over 15% to lead the S&P 500 gainers, reflecting strong demand for tech stocks and a recovery in investor confidence.
- Energy Stocks Under Pressure: Energy producers faced headwinds as WTI crude oil prices fell more than 4%, with Diamondback Energy (FANG) and Occidental Petroleum (OXY) both declining over 3%, indicating growing concerns in the energy sector.
- Cryptocurrency Market Retreats: Bitcoin plummeted over 7% to a 9.75-month low, leading to widespread declines in cryptocurrency-related stocks, with Galaxy Digital Holdings (GLXY) and Strategy (MSTR) both dropping over 6%, reflecting weakened investor confidence in the crypto market.
See More
US Stocks Rise as Chip and Rare Earth Stocks Rebound
- Market Recovery: The S&P 500 index rose by 0.39%, the Dow Jones Industrial Average increased by 0.84%, and the Nasdaq 100 climbed by 0.64%, reflecting positive market sentiment driven by strong economic signals, particularly following the expansion of the manufacturing index.
- Rare Earth Stocks Surge: President Trump's plan to launch a $12 billion strategic stockpile of critical minerals to reduce reliance on China has led to a rise in US rare earth stocks, with USA Rare Earth up over 12% and United States Antimony Corp up over 6%, indicating a positive impact from supportive policies on the sector.
- Energy Stocks Under Pressure: WTI crude oil prices fell by more than 4%, primarily due to easing geopolitical risks, putting pressure on energy producers, with companies like ConocoPhillips and Chevron seeing declines of over 2%, reflecting market concerns about energy demand prospects.
- Cryptocurrency Market Retreats: Bitcoin prices dropped over 7% to a 9.75-month low, leading to widespread declines in cryptocurrency-related stocks, with Galaxy Digital Holdings down more than 4%, highlighting a weakening market confidence in crypto assets.
See More
Wall Street Rebounds as Precious Metals Face Pressure
- Market Rebound: Wall Street experienced a rebound at the start of the new month, with the S&P 500 rising 0.7% and the Nasdaq 100 gaining 1.1%, while the Russell 2000 rebounded 1.4% after a 1.6% drop, indicating strong performance in small-cap stocks and reflecting improved investor sentiment.
- Pressure on Precious Metals: Gold prices extended Friday's decline, sliding over 4% to $4,670 per ounce, while silver plummeted 8% to $77.88, indicating ongoing pressure in the precious metals market as investors reassess the Federal Reserve's policy outlook.
- Positive Economic Data: The ISM Manufacturing PMI unexpectedly surged to a three-year high, signaling renewed momentum in factory activity and boosting market confidence in economic recovery, despite the Bureau of Labor Statistics delaying the release of January's jobs report due to the partial government shutdown.
- Energy Market Volatility: Natural gas prices plunged 25% on milder weather forecasts, while crude oil dropped over 5% as the U.S. administration prepared for nuclear deal talks with Iranian officials, highlighting the impact of geopolitical factors on energy markets.
See More
